Skip to content

Decipher Prostate Biopsy Test Report Overview

We want you to feel confident in every treatment decision you make using Decipher Prostate for your patients with prostate cancer, beginning with a clear understanding of how to interpret the key components of the biopsy test report.

View Interactive Test Report
Home > Decipher Prostate > Physicians > Biopsy Test Report Overview

Page 1 contains the Decipher Score, risk estimates, and an interpretation of the score.

Biopsy Report Guide Page 1 1

1. Dynamic Report

The report is tailored to the clinical presentation of this patient

 2

2. Decipher Score

  • Reflects genomic risk of metastasis
  • Determined by tumor biology alone, independent of clinical & pathological factors (e.g., Gleason, PSA)
  • 22 genes, 7 biological pathways
  • Continuous genomic risk score classified as low, intermediate or high
 3

3. Interpretation

Summary based on this patient’s genomic risk & relevant clinical findings

 4

4. Risk Estimates

  • Calibrated to outcomes of patients treated with definitive therapy appropriate for this patient’s NCCN risk group
    • Metastasis at 5 & 10 years
    • Prostate Cancer Mortality at 15 years
    • Adverse Pathology at RP (Grade Group 3-5, pT3b-T4, or lymph node involvement)

Page 2 contains case analysis, interpretation, and clinical findings.

Biopsy Report Guide Page 2 5

5. Interpretation

  • Explains risk comparison graphic
  • Provides this patient’s percentile rank in the tested population
 6

6. Risk Comparisons

  • This patient’s 10-year risk of metastasis with respect to 27,926 other NCCN Favorable Intermediate Risk patients
  • The distribution of Decipher risk within the 27,926 patients is:
    • 52% Decipher Low
    • 22% Decipher Int.
    • 26% Decipher High
 7

7. Clinical Findings

Clinical study results relevant to this patient

Page 3 contains a test description, intended use info, confidence intervals, and references.

Biopsy Report Guide Page 3 8

8. Test Description

  • Description of:
    • Decipher testing platform technology
    • Risk estimates
    • Cut-points separating Decipher low, intermediate & high
 9

9. Intended Use

Decipher Prostate Biopsy is intended for use in biopsy specimens from patients with localized or pelvic node positive prostate cancer to help inform treatment decisions

 10

10. Confidence Intervals

The 95% confidence intervals for each risk estimate (on page 1)

 11

11. References

For each of the clinical studies cited in the report